You are here

P&T November 2011

Features

Continuous infusions of ceftazidime for pulmonary exacerbations were found to be safe and effective, with the potential to reduce the costs of therapy, enhance patients’ quality of life, and eradicate resistant isolates of Pseudomonas aeruginosa.

Causes, Impact, and Management Strategies
$1 Billion Is Available to Fight Medical Errors and Reduce Readmissions